Product-118

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameProduct-118
Drug Alias Namedrug-device combination therapy (Anessa Pharma/Prexa Santé)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexico
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAnessa Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesAnessa Pharma LLCPrexa Santé
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A